JNJ - JOHNSON & JOHNSON
155.38
-2.370 -1.525%
Share volume: 9,051,576
Last Updated: 04-23-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.02%
PREVIOUS CLOSE
CHG
CHG%
$157.75
-2.37
-0.02%
View ratios
Fiscal Date | 04-02-2023 | 07-02-2023 | 10-01-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-29-2024 | 12-29-2024 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 04-28-2023 | 07-31-2023 | 10-27-2023 | 02-13-2025 | 05-01-2024 | 07-25-2024 | 10-23-2024 | 02-13-2025 | |
Cash flow financing | 6.138 B | -5.991 B | -11.317 B | -4.655 B | 546.000 M | 7.544 B | -9.882 B | -1.340 B | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | -94.000 M | 423.000 M | -822.000 M | 148.000 M | 391.000 M | |
Cash flow | 3.257 B | 4.182 B | 7.489 B | 2.006 B | 3.739 B | -510.000 M | -5.017 B | 4.323 B | |
Net income | -68.000 M | 5.144 B | 26.028 B | 4.049 B | 3.255 B | 4.686 B | 2.694 B | 3.431 B | |
Depreciation | 1.880 B | 1.934 B | 1.829 B | 1.843 B | 1.815 B | 1.782 B | 1.846 B | 1.896 B | |
Changes in inventories | 12.809 B | 12.888 B | 11.198 B | 0.000 | 348.000 M | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 16.350 B | 16.777 B | 14.798 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | 3.315 B | -3.776 B | 2.541 B | -1.202 B | -464.000 M | -13.687 B | -3.128 B | -1.320 B | |
Net Borrowings | 25.373 B | 14.700 B | 2.214 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | -1.942 B | 1.595 B | -251.000 M | -1.997 B | 1.996 B | |
Dividends Paid | 0.000 | 0.000 | 0.000 | -2.865 B | -2.869 B | -2.985 B | -2.985 B | -2.984 B | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -863.000 M | -1.124 B | -967.000 M | 1.468 B | 597.000 M | 613.000 M | 979.000 M | 1.560 B | |
Cash Change | 24.613 B | 28.505 B | 23.511 B | 2.131 B | 3.614 B | -595.000 M | -4.898 B | 4.125 B |